ClinicalTrials.Veeva

Menu
P

Premier Medical Group | Clarksville, TN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-3655-001
ALO-01
Ritonavir
Naltrexone Hydrochloride
PF-07321332
Morphine Sulfate
MK-3655
Resmetirom

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 6 total trials

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepat...

Enrolling
NASH
Cirrhosis, Liver
Drug: Resmetirom
Drug: Placebo

Trial sponsors

Pfizer logo
Madrigal Pharmaceuticals logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems